To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.
Van Calster, B., Van Hoorde, K., Valentin, L., Testa, A. C., Fischerova, D., Van Holsbeke, C., Savelli, L., Franchi, D., Epstein, E., Kaijser, J., Van Belle, V., Czekierdowski, A., Guerriero, S., Fruscio, R., Lanzani, C., Scala, F., Bourne, T., Timmerman, D., Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study, <<BMJ BRITISH MEDICAL JOURNAL>>, 2014; 349 (Ottobre): g5920-g5920. [doi:10.1136/bmj.g5920] [http://hdl.handle.net/10807/64603]
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
Testa, Antonia Carla;
2014
Abstract
To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.
| File | Dimensione | Formato | |
|---|---|---|---|
|
bmj.g5920.full.pdf
accesso aperto
Descrizione: Full Article Free
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.97 MB
Formato
Adobe PDF
|
1.97 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
